[1]
William Muehlebach 2025. Investigating the Effects of Doxorubicin on Mesenchymal Versus Basal Triple Negative Breast Cancer Survival in 3D Culture. Kansas Journal of Medicine. 18, S3 (Sep. 2025), 14. DOI:https://doi.org/10.17161/kjm.vol18.24433.